Clear Street Group Inc. Buys 266,975 Shares of Astera Labs, Inc. $ALAB

Posted by Brenda Bartman on Jun 14th, 2026

Clear Street Group Inc. boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 86.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 577,211 shares of the company’s stock after purchasing an additional 266,975 shares during the quarter. Astera Labs comprises about 0.4% of Clear Street Group Inc.’s investment portfolio, making the stock its 20th largest holding. Clear Street Group Inc.’s holdings in Astera Labs were worth $96,025,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. bought a new stake in Astera Labs in the fourth quarter valued at about $18,708,000. Nordea Investment Management AB bought a new stake in Astera Labs in the fourth quarter valued at about $2,028,000. Geneva Partners LLC bought a new stake in Astera Labs in the third quarter valued at about $1,876,000. Numerai GP LLC increased its holdings in Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the last quarter. Finally, Swedbank AB increased its holdings in Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the sale, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. The trade was a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,321,256 shares of company stock valued at $480,893,146 over the last three months. Company insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ALAB shares. Roth Mkm reiterated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. TD Cowen boosted their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Susquehanna boosted their target price on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Loop Capital initiated coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Get Our Latest Report on ALAB

Astera Labs Price Performance

ALAB stock opened at $367.15 on Friday. The stock has a market capitalization of $62.93 billion, a P/E ratio of 248.07, a P/E/G ratio of 4.86 and a beta of 3.95. The business has a 50-day moving average of $237.17 and a 200-day moving average of $178.94. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $390.99.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.